Kuros Biosciences’ Post

MagnetOs grows bone thanks to its unique NeedleGrip™ surface technology - which has been shown in pre-clinical studies to stimulate stem cells to form new bone across the entire graft. *†¹˒² But how does it perform in humans? In the independent Level 1 human clinical study recently published in Spine, MagnetOs outperformed autograft significantly (𝟳𝟵% 𝘃𝘀. 𝟰𝟳% 𝗳𝘂𝘀𝗶𝗼𝗻 𝗿𝗮𝘁𝗲). ³ Visit our Evidence Center to learn more about the details of this Level 1 trial – and what it means for you → https://lnkd.in/e5K7XtsM #KurosBiosciences #MagnetOs #Level1Data #GrowBoneMagnetOs #NeedleGrip

David Plane

Founding Director at LEDA Orthopaedics & Ortholove. Co-founder/investor at RAVL. Trustee/fundraiser for The Sick Children's Trust.

2mo

So exciting to see the uptake of #MagnetOs in extremities surgery and look forward to seeing similar results for foot & ankle fusions and non-union cases in the UK

Lisa King, BCMAS, CCRP, PhD

Experienced Clinical Research Specialist | Clinical Trial Management, Regulatory Compliance & Business Development | Driving Operational Excellence & Advancing Medical Affairs | Ph.D., CCRP, BC-MAS, AI Certified

2mo

This is exciting news for the field of bone grafting and orthopedic surgery. The Level 1 clinical study results are impressive and demonstrate the efficacy of MagnetOs in promoting bone growth. The NeedleGrip™ surface technology is a unique feature that sets MagnetOs apart from other bone grafting materials. It's great to see that pre-clinical studies have translated into positive clinical outcomes for patients. This could potentially revolutionize the way bone grafting is done and improve patient outcomes. Kudos to Kuros Biosciences for developing such an innovative product.

See more comments

To view or add a comment, sign in

Explore topics